Levitronix
Transcription
Levitronix
About Levitronix: CentriMag® VAS U.S. Clinical Trials Patient & System ICU Management Levitronix LLC Confidential 1 Levitronix is a world leader in magnetically levitated Bearingless Motor technology, specializing in the development of “Third Generation” blood pumps. Copyright Protected (7/05) ® 2 Copyright Protected (7/05) CentriMag® Characteristics CentriMag VAS System • No bearings, seals, valves, or diaphragms – No wearing parts, friction, or heat generation in the blood path, reducing the risk for thrombus formation and hemolysis. • Elimination of bearings and seals allows uniform washing of the rotor surface and minimizes areas of blood stagnation and turbulence in the pump. and Flow Probe • Large mechanical gaps in the pump (>0.6mm) allows the shear forces to be low, greatly reducing hemolysis. • Cannulae, Tubing • The system can be used for up to 14 days of continual use. • The system is capable of providing flow up to 9.9 liters per minute under normal physiologic conditions. • CentriMag Blood Pump and Motor • Console, Cables and Connectors Levitronix LLC Confidential Levitronix LLC Confidential 3 Copyright Protected (7/05) Levitronix LLC Confidential 4 Copyright Protected (7/05) Example Case - 51 Year Old Male Objectives of LV/RV support • AMI requiring hospital admission • Emergent CABG, IABP • Day 6: Transfer to VAD/ Transplant Centre • Ventilator, IABP, inotropic support • Haemodynamics: C.I. 1.6, mABP 66, EF 8% • Neurologic status: unknown • Day 6: LVAD ! BVAD ! BVAD + ECMO • Day 11: Weaned from ECMO to BVAD • Day 17: Bridged to HeartMate® VE LVAD • Day 39: Discharge to Home on HeartMate® VE • Now: LVAD & Awaiting Heart Transplantation Levitronix LLC Confidential 5 Copyright Protected (7/05) • Provide essential circulatory support • Unload and decompress the ventricles • Reduce myocardial work • Reduce myocardial oxygen demand • Reduce myocardial edema • Regain ventricular function • Post AMI: Prevent over distention, facilitate solid scar formation, limit extent of evolving infarction. Levitronix LLC Confidential 6 Copyright Protected (7/05) Cannulation for RVAD Support RVAD Trial Objectives • To evaluate use of the Levitronix CentriMag® Ventricular Assist System as an RVAS following implantation of a commercially approved LVAS. • Demonstrate safe and effective use for 14 days. • To serve as a bridge to recovery, bridge to longterm support with a commercially approved device or bridge to heart transplantation. • Improvement of the protocols, study design, training, VAD system, and system components. Levitronix LLC Confidential 7 Copyright Protected (7/05) Levitronix LLC Confidential 8 Copyright Protected (7/05) CentriMag Control Panel CentriMag® Console Control Panel • Row 1 - Information • Speed and RPM displays & bars, battery gauge, and power icons • Row 2 - Alphanumeric Display (4 lines) • Lines 1 & 2 display system status • Line 3 displays selected system parameters • Line 4 displays keypad descriptions • Row 3 - Keypads • Alarm Silence, Menu Options, Speed Adjustment, Pump Stop Levitronix LLC Confidential 9 Copyright Protected (7/05) Levitronix LLC Confidential 10 Copyright Protected (7/05) Normal Operating Conditions CentriMagR Control Panel Alarm Acknowledge - Depressing will silence audio alarm. Message remains displayed. Alarm messages will be displayed in order of priority. Menu – Allows user to select system one of three settings to view or modify e.g. (Adjust RPM, minimum flow alarm level, or audio volume). Set Pump RPM – When ‘SET RPM’ is displayed depress for speed adjustment. If ‘EXIT’ is displayed depress to store value. RPM will remain at set rate. Decrease - Allows user to decrease selected parameter. Increase - Allows user to increase selected parameter. • Pump Speed : 3000 – 4000 RPM • RVAD Flow: 4 – 5 LPM • CVP / RAP: 10 – 15 mm Hg • ACT: 190 - 210 by 4th post-op day Emergency Stop – Depressing for 2 seconds will cause the pump to STOP. Levitronix LLC Confidential 11 Copyright Protected (7/05) Levitronix LLC Confidential 12 Copyright Protected (7/05) Management Points • • • • • • • Potential Early Complications VAS system has no auto-control “Similar to other VADs” Adjustments in flow must be gradual Periodic flow reduction to wash ventricles • Bleeding • Arrhythmias Avoid conditions that result in line “chatter” • Tamponade • Variable volume Avoid flexing of tubing near the connectors • Reoperation • Variable VAS flow Balance left & right atrial pressure not flows • “HIT” • Right ventricular failure Forces are easily transmitted through tubing Levitronix LLC Confidential 13 Copyright Protected (7/05) Adjust VAD RPM For: 14 Copyright Protected (7/05) Potential Causes of Low VAD Flow • Low flow with line chatter/ shaking • Low volume / low pressure (CVP) • Periodically (when ordered) • To wash ventricles and valves • Respiratory therapy (if necessary) Levitronix LLC Confidential Levitronix LLC Confidential 15 • • • • • • • Copyright Protected (7/05) Interstitial edema Cardiac tamponade Pulmonary vascular resistance Cannulae selection and position Operating at too high of an RPM Ventricular function/ dysfunction Hypovolemia (Bleeding, Fluid Balance) Levitronix LLC Confidential 16 Copyright Protected (7/05) Anticoagulation Guidelines* • • • • • • • • • More Aggressive Anticoagulation • Short or no cardiopulmonary bypass • Normal of hypercoaguable profile • Clot formation in circuit or pump • Low flow (<4 LPM) or high RPMs Target PTT 1.3-1.6 (eg. 39 – 48 sec) times normal • Circuit Design (connectors, Leur, etc…) Increase Target ACT & PTT approx. 5% each day • Oxygenator or heat exchanger Target ACT of 190-210 by 4th post op day • Infection or inflammatory process Target PTT 1.5-1.8 times normal by 4th post op day • High platelet count (>100k) Add platelet anti-aggregant by the 4th postop day (eg. 81- 325 mg aspirin per day) by the 4th postop day • High fibrin level • Prosthetic valve, patch, or ring. CentriMag VAD flow > 4.0 LPM No anticoag. for 6-12 hrs unless no CPB for implant Start heparin infusion if CT < 50 cc/hr for 2-3 hrs Target ACT 160-180 sec (Hemochron Celite ACT) Levitronix LLC Confidential 17 Copyright Protected (7/05) History of “bleeding”. • Hepatic and/or renal dysfunction • Patient temperature – hypothermia • Abnormal platelet function Levitronix LLC Confidential 18 Copyright Protected (7/05) Hemostasis Management Less Aggressive Anticoagulation • Levitronix LLC Confidential 19 Copyright Protected (7/05) • LABORATORY STUDIES: • TREATMENT OPTIONS: • ACT, PT, INR, PTT • Platelets • Fibrinogen • FFP, Cryoprecipitate • Platelet count and function • Protamine Sulfate • Amicar, Aprotinin • Vitamin K Levitronix LLC Confidential 20 Copyright Protected (7/05) Study Daily Data Requirements • CentriMag® System Checks (Q 1-2°) Hemodynamics • HR, TEMP, CVP, PAP, PCWP, ABP, CO • RVAD RPM & LPM, LVAD RPM & LPM • Laboratory • CBC, Chem13, LDH, PFHgb, Coags, ACT • Neurologic • • • • ACT within target range? • Record VAD flow and RPMs with VS Line chattering or shaking? Color of urine for hemolysis? Reduce VAD flows to wash valves aortic root, and ventricles. • Glascow Coma Scale Levitronix LLC Confidential 21 Copyright Protected (7/05) CentriMag® System Checks (Q Shift) • • • • • • • • • • • • • • • • • Tubing secured to patient? Circuit bends wide and smooth? On AC power and battery fully charged? Air circulation around motor & console? Two tubing clamps near each blood pump? Backup console ready with battery charged? Low flow alarm set 1.0 LPM less than target? Review “Emergency Switch to Backup” ref. card Practice pump “Switch” with the backup console 23 22 Copyright Protected (7/05) CentriMag® System Checks (Q Day) Move flow probe ~1 cm Levitronix LLC Confidential Levitronix LLC Confidential Copyright Protected (7/05) Study GCS, labs and hemodynamics recorded? Pump properly mounted with screw in notch? Strain relief (sleeve) on the pump connectors? Inspect circuit and connectors with flashlight Minimal or no tubing movement during inspection Emergency supplies (pump, tubing, etc.) present? Motor and motor clamp out of harms way & secure? Levitronix LLC Confidential 24 Copyright Protected (7/05) Patient Movement & Transport • Risk of decannulation is greater during transport of the patient • Continuously monitor patient’s hemodynamics and VAD flows • Assign one individual to monitor VAD consoles and blood pumps • Place blood pump and motor on the bed between the patients legs • • Insure pumps are not covered • Each console has approximately 1 hr of battery power EMERGENCY SWITCH TO BACKUP Backup console and clamps must always be with the patient Levitronix LLC Confidential RPM > 1000 25 Copyright Protected (7/05) Review Questions: • • • • • • • Typical battery life for each console? Action to take for low flow or line shaking? Target CVP? Must L. and R. flow be equal? What value should the flow alarm be set at? Expected RPM and LPM values on console? Indicators that the pump is mounted correctly? Backup items required with patient at all times? Levitronix LLC Confidential 27 Copyright Protected (7/05) Levitronix LLC Confidential 26 Copyright Protected (7/05)